Generation of (E)-1-(2,3,6-Trimethylphenyl)buta-1,3-diene
J. Agric. Food Chem., Vol. 53, No. 17, 2005 6779
100 mL coil only. The revolution speed was set at 800 rpm, the
temperature was kept at 25 °C, and the flow rate was delivered at 1.5
mL/min by a Waters 600E pump. The elution was monitored by a GBC
LC1210 UV-vis detector (320 nm) and UPC-900 detector (254 nm)
(Amersham Pharmacia Biotech, Sweden). Chromatograms were re-
corded using Agilent Chemstation software. The Riesling glycosidic
extract (approximately 300-400 mg) was dissolved in a (50/50 v/v)
mixture of the upper and lower phases of the solvents, filtered through
a 0.45 µm filter (Millipore) prior to injection through a (2 mL)
Rheodyne injection loop. A methanol-gradient solvent system consisting
of chloroform/methanol/water (7/x/8) was used. The proportion of
methanol was reduced, at 30 min intervals, from 13 parts to,
successively, 10, 7, 4, and one part (i.e., from x ) 13 to x ) 1, via x
) 10, x ) 7, and x ) 4). The solvents were sonicated for 30 min
before use. The elution mode of the mobile phase was tail-to-head,
with the less dense layer (aqueous) being the mobile phase. Eighty
fractions (3 mL) were collected with a fraction collector. Fractions were
also screened by enzyme hydrolysis, followed by GC-MS analysis.
In total, 9 runs of approximately 300-400 mg material per run were
performed and combined based on their 254 nm detection. The average
stationary phase retention was 88% before injection and 50% after
injection.
Separation 2: Isocratic Chloroform/Methanol/Water (7/13/8). Frac-
tions 11-25 (approximately 800-900 mg) from separation 1 were
further separated on a 200 mL coil (2 × 100 mL coils joined in tandem)
as per separation 1, but an isocratic solvent system was used with 13
parts methanol. The stationary phase retention was 50% before injection,
and 24% after injection. A total of 120 fractions (3 mL) were collected.
Separation 3: Isocratic Butanol/Ethyl Acetate/Water (2/3/5). Frac-
tions 51-60 from separation 2 (approximately 200-300 mg) were
further purified on a 200 mL analytical column coil (2 × 100 mL coils
joined in tandem) as per separation 1. However, an isocratic butanol/
ethyl acetate/water (2/3/5) solvent system was used. The stationary
phase retention before injection was 89% and 82% after injection. A
total of 110 fractions (5 mL) were collected. The above 3 separations
resulted in a clear oil for fractions 56-63 (31 mg, >95% purity) which
was found to be 4,5-dihydrovomifoliol-â-D-glucopyranoside (9b). The
spectroscopic data for 9b was consistent with that reported by Inada et
al. (18).
Enzyme Hydrolysis. The glycosidic extract (10-15 mg) was
dissolved in pH 5 phosphate-citrate buffer (0.5 mL) and an equivalent
mass of AR 2000 glycosidase enzyme preparation was added. The vial
was capped under nitrogen, and the solutions were incubated for 16 h
at 40 °C. The aglycones were then extracted with dichloromethane:
pentane (1:2; 5 × 1 mL) and diethyl ether:dichloromethane (3:1; 2 ×
1 mL) and filtered, and the organic portion was dried through a plug
of cotton wool containing Na2SO4. Internal standard (25 µL of 600
mg/L 3,5-dimethylphenol) was added, and the extract was then analyzed
directly by GC-MS.
4,5-Dihydrovomifoliol (9a). The glycoside (9b) (10 mg) was treated
with AR 2000 as described above. δH (CDCl3): 5.84 (1H, dd, J )
15.8, 5.6, H8), 5.70 (1H, dd, J ) 15.8, 1.1, H7), 4.44 (1H, app quin, J
) 6.1, H9), 2.84 (1H, d, J ) 13.5, H2a), 2.15-2.50 (3H, m, H4a,4b,5),
1.92 (1H, dd, J ) 13.5, 2.2, H2b), 1.33 (3H, d, J ) 6.5, H10), 0.97, 0.94
(6H, 2xs, H11,12), 0.88 (1H, d, J ) 6.5, H13). MS m/z (%): 208 ((M-
H2O)+, 9), 193 (2), 169 (7), 165 (13), 152 (9), 141 (31), 129 (27), 124
(33), 111 (31), 109 (51), 97 (33), 95 (42), 85 (100), 71 (71), 55 (35),
43 (71).
m, H3,9), 2.80-2.15 (3H, br s, 3OH), 1.88-1.44 (5H, m, H2,13), 1.26
(3H, d, J ) 6.5, H10), 0.98, 0.89 (6H, 2s, H11,12). δH (d6-acetone):
(major isomer) 5.84 (1H, ddd, J ) 15.6, 5.9, 2.3, H8), 5.61 (1H, dd, J
) 15.5, 1.0, H7), 5.48 (1H, m, H4), 4.44-4.08 (2H, m, H3,9), 3.88-
3.28 (3H, br s, 3OH), 1.80-1.50 (5H, m, H2,13), 1.22 (3H, d, J ) 6.5,
H10), 0.99, 0.88 (6H, 2 s, H11,12).
3,4,9-Trihydroxymegastigma-5,7-diene (4). The triols (6) (111 mg,
0.49 mmol) were dissolved in pH 3.0 aqueous buffer solution (14 mL)
and heated on a boiling water bath in a stoppered round-bottom flask
for 15 min. The reaction mixture was cooled and extracted with
dichloromethane (2 × 10 mL) and chloroform (12 × 10 mL). The
organic layers were combined, dried, and concentrated in vacuo to yield
a yellow oil (93 mg). The crude reaction mixture was subjected to 2
silica chromatography columns (column 1 eluant, methanol/dichlo-
romethane gradient; column 2 eluant, ethyl acetate) to give the triols
(4) as a mixture of diastereomers (39 mg, 35%). δH (CDCl3): (major
isomer) 6.00 (1H, br d, J ) 16.0, H7), 5.53 (1H, dd, J ) 16.0, 6.3, H8),
4.37 (1H, app quin, J ) 6.3, H9), 4.00-3.70 (2H, m, H3,4), 2.34 (3H,
br, 3 OH), 1.82 (3H, br s, H13), 1.76-1.40 (2H, m, H2a,2b), 1.30 (3H,
d, J ) 6.3, H10), 1.04, 1.01 (6H, 2s, H11,12). δH (d4-MeOH): (major
isomer) 6.07 (1H, d, J ) 16.1, H7), 5.40 (1H, ddd, J ) 16.1, 6.2, 1.7,
H8), 4.05 (1H, app quin, J ) 6.3, H9), 3.87 (1H, br d, J ) 3.3, H4),
3.79 (1H, m, H3), 1.86 (3H, br s, H13), 1.78 (1H, m, H2a), 1.45 (1H,
ddd, J ) 12.3, 3.6, 1.3, H2b), 1.29 (3H, d, J ) 6.3, H10), 1.07, 1.10
(6H, 2s, H11,12).
A second fraction (31 mg) was also isolated with the hydroxyketone
12 as the major product, and the diastereomeric actinidols (8a/b) were
isolated as a minor component. The spectroscopic data for 12 was in
agreement with that of Strauss et al. (6).
Actinidols (8). The triols (6) (70 mg, 0.31 mmol) were dissolved in
pH 3.0 aqueous buffer solution (7 mL) and heated under reflux for 30
min. The reaction mixture was then cooled to room temperature and
extracted with diethyl ether (2 × 5 mL). The hydrolysis and extraction
step was then repeated 7 times. The organic layers were combined,
dried, and concentrated in vacuo to yield the crude product (60 mg).
This was purified by two silica chromatography columns (column 1
elutant, ethyl acetate; column 2 elutant, 30% ethyl acetate in pentane)
to give the actinidols (8a/b) as a mixture of diastereomers (8 mg, 13%),
in approximately a 1.3 to 1 ratio. The hydroxyketone (12) (18 mg,
31%) and diastereomeric 3,4,9-trihydroxymegastigma-5,7-dienes (4) (25
mg, 36%) were also isolated. δH (CDCl3): (major isomer of 8, consistent
with isomer (Kovats index (KI) 1200) reported by Dimitriadis et al.
(9)) 5.78 (1H, m, H4), 5.62 (1H, dt, J ) 10.3, 3.2, H3), 5.30 (1H, br s,
H7), 4.60 (1H, dd, J ) 4.9, 1.1, H8), 3.60 (1H, qd, J ) 6.3, 4.9, H9),
2.01 (2H, dd, J ) 3.2, 1.4, H2), 1.44 (3H, s, H13), 1.22 (3H, s, H11),
1.17 (3H, d, J ) 6.3, H10), 1.14 (3H, s, H12). δC (CDCl3): 154.0, 132.3,
126.2, 117.5, 86.6, 86.2, 69.9, 43.3, 34.1, 28.7, 26.7, 26.4, 19.2. MS
m/z (%): 193(2), 175(1), 164(14), 163(100), 157(1), 149 (12), 145-
(13), 135(5), 131(5), 121(14), 119(7), 107(11), 105(12), 93(10), 91-
(12), 79(10), 77(10), 55(6), 43(23).
δH (CDCl3): (minor isomer of 8, consistent with isomer (KI 1211)
reported by Dimitriadis et al. (9)) 5.79 (1H, m, H4), 5.59 (1H, dt, J )
10.0, 3.2, H3), 5.37 (1H, br s, H7), 4.75 (1H, dd, J ) 3.0, 1.1, H8), 3.81
(1H, qd, J ) 6.6, 3.1, H9), 2.01 (2H, dd, J ) 3.2, 1.4, H2), 1.45 (3H,
s, H13), 1.23 (3H, s, H11), 1.15 (3H, d, J ) 6.6, H10), 1.14 (3H, s, H12).
δC (CDCl3): 154.5, 132.0, 126.7, 115.5, 86.3, 86.0, 68.4, 43.3, 34.2,
28.6, 26.6, 26.2, 17.5. MS m/z (%): 193(3), 175(1), 164(15), 163-
(100), 157(1), 149 (12), 145(13), 135(4), 131(4), 121(13), 119(7), 107-
(9), 105(12), 93(9), 91(10), 79(6), 77(7), 55(3), 43(13).
Generation of 1 by Acid Hydrolysis. Solutions of each of the
compounds, 4, 6, and 8, as well as glycoside 9b, were prepared by
dissolving the particular compound (1.0 mg/L) in pH 3.2 model wine.
The solutions were transferred into glass ampules and sealed under
nitrogen. The ampules were heated at 25 °C, 45 °C or 100 °C. Duplicate
ampules were removed at selected times, opened, and the concentration
of 1 determined (2).
3,6,9-Trihydroxymegastigma-4,7-diene (6). Dehydroionone (10)
(0.404 g, 2.13 mmol) was converted into 3,6-dihydroxymegastigma-
4,7-dien-9-one (11) (299 mg, 63%) as described by Strauss et al. (6).
A portion of this product (150 mg, 0.67 mmol) was dissolved in
methanol (10 mL) and CeCl3‚7H2O (93.5 mg, 0.25 mmol) and NaBH4
(18 mg, 0.48 mmol) were added. After 10 min water (10 mL) was
added slowly and the solution was saturated with NaCl. The reaction
mixture was extracted with dichloromethane and diethyl ether, the
extracts were combined, dried with Na2SO4 and concentrated in vacuo
to yield a pale yellow oil (91 mg). The crude reaction mixture was
purified by two silica chromatography columns (eluant, ethyl acetate)
to yield the dienes (6) as a mixture of diastereomers (26 mg, 17%). δH
(CDCl3): (major isomer) 6.00-5.25 (3H, m, H4,7,8), 4.50-4.00 (2H,
RESULTS AND DISCUSSION
Isolation of Pure 4,5-Dihydrovomifoliol-C9-â-D-glucopy-
ranoside. MLCCC was employed for the isolation of individual